$AAQL
Antiaging Quantum Living Inc.

2022 Q4 Form 10-Q Financial Statement

#000149315222031621 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $4.000K $6.000K $1.800K
YoY Change 185.71% 233.33% 350.0%
Cost Of Revenue $600.00
YoY Change 100.0%
Gross Profit $4.000K $6.000K $1.200K
YoY Change 344.44% 400.0% 1100.0%
Gross Profit Margin 100.0% 100.0% 66.67%
Selling, General & Admin $10.77K $7.520K $8.830K
YoY Change -46.7% -14.84% -58.05%
% of Gross Profit 269.3% 125.33% 735.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.00 $80.00 $30.00
YoY Change 166.67% 166.67%
% of Gross Profit 2.0% 1.33% 2.5%
Operating Expenses $10.77K $7.520K $8.830K
YoY Change -46.7% -14.84% -58.05%
Operating Profit -$6.772K -$1.520K -$7.630K
YoY Change -64.93% -80.08% -63.58%
Interest Expense $0.00 $0.00 $700.00
YoY Change -100.0% -20.45%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$6.772K -$1.520K -$6.930K
YoY Change -64.93% -78.07% -65.47%
Income Tax
% Of Pretax Income
Net Earnings -$6.772K -$1.520K -$6.930K
YoY Change -64.93% -78.07% -65.47%
Net Earnings / Revenue -169.3% -25.33% -385.0%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 -$50.68 -$231.00
COMMON SHARES
Basic Shares Outstanding 30.00M shares 30.00M shares 30.00M shares
Diluted Shares Outstanding 30.00M shares 30.00M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $900.00 $1.300K $48.17K
YoY Change -94.19% -97.3% 69.91%
Cash & Equivalents $901.00 $1.301K $48.17K
Short-Term Investments
Other Short-Term Assets $510.00
YoY Change
Inventory
Prepaid Expenses $506.00
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $1.407K $1.301K $48.17K
YoY Change -90.92% -97.3% -45.28%
LONG-TERM ASSETS
Property, Plant & Equipment $619.00 $697.00 $920.00
YoY Change -30.45% -24.24%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $619.00 $697.00 $920.00
YoY Change -30.45% -24.24%
TOTAL ASSETS
Total Short-Term Assets $1.407K $1.301K $48.17K
Total Long-Term Assets $619.00 $697.00 $920.00
Total Assets $2.026K $1.998K $49.09K
YoY Change -87.63% -95.93% -44.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $600.00
YoY Change -88.0%
Accrued Expenses
YoY Change
Deferred Revenue $4.000K $3.200K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $76.30K $70.90K
YoY Change
Total Short-Term Liabilities $80.90K $74.10K $4.600K
YoY Change 886.59% 1510.87% 4.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $71.00K
YoY Change -100.0% -100.0% 0.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $71.00K
YoY Change -100.0% -100.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $80.90K $74.10K $4.600K
Total Long-Term Liabilities $0.00 $0.00 $71.00K
Total Liabilities $80.90K $74.10K $75.60K
YoY Change 30.06% -1.98% 0.27%
SHAREHOLDERS EQUITY
Retained Earnings -$269.1K -$262.3K
YoY Change
Common Stock $30.00K $30.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$78.87K -$72.10K -$26.51K
YoY Change
Total Liabilities & Shareholders Equity $2.026K $1.998K $49.09K
YoY Change -87.63% -95.93% -44.23%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$6.772K -$1.520K -$6.930K
YoY Change -64.93% -78.07% -65.47%
Depreciation, Depletion And Amortization $80.00 $80.00 $30.00
YoY Change 166.67% 166.67%
Cash From Operating Activities -$5.800K -$9.680K -$4.600K
YoY Change -63.01% 110.43% -97.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$950.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $52.44K
YoY Change -100.0% 162.2%
Cash From Investing Activities $0.00 $0.00 $51.49K
YoY Change -100.0% 157.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.400K 9.900K 0.000
YoY Change -131.76%
NET CHANGE
Cash From Operating Activities -5.800K -9.680K -4.600K
Cash From Investing Activities 0.000 0.000 51.49K
Cash From Financing Activities 5.400K 9.900K 0.000
Net Change In Cash -400.0 220.0 46.89K
YoY Change -98.78% -99.53% -135.22%
FREE CASH FLOW
Cash From Operating Activities -$5.800K -$9.680K -$4.600K
Capital Expenditures $0.00 -$950.00
Free Cash Flow -$5.800K -$3.650K
YoY Change -63.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001672571
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
usd
us-gaap Interest Income Other
InterestIncomeOther
usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
usd
ACHN Proceeds From Collection Of Notes Receivables
ProceedsFromCollectionOfNotesReceivables
usd
ACHN Payments To Property Plant And Equipment
PaymentsToPropertyPlantAndEquipment
usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
usd
CY2021Q1 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56157
dei Entity Registrant Name
EntityRegistrantName
Achison Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-2643986
dei Entity Address Address Line1
EntityAddressAddressLine1
135-22 Northern Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
2nd Fl
dei Entity Address City Or Town
EntityAddressCityOrTown
Flushing
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
11354
dei City Area Code
CityAreaCode
(917)
dei Local Phone Number
LocalPhoneNumber
470-5393
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29995000 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1301 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14269 usd
us-gaap Cost Of Revenue
CostOfRevenue
600 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1301 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
14269 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
697 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
854 usd
CY2022Q3 us-gaap Assets
Assets
1998 usd
CY2022Q1 us-gaap Assets
Assets
15123 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3200 usd
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5600 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
70900 usd
CY2022Q1 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
59000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
74100 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
64600 usd
CY2022Q3 us-gaap Liabilities
Liabilities
74100 usd
CY2022Q1 us-gaap Liabilities
Liabilities
64600 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29995000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29995000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
29995 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
160230 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-262327 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-239702 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-72102 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1998 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15123 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1800 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8400 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3600 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
600 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31025 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
6000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
1200 usd
us-gaap Gross Profit
GrossProfit
8400 usd
us-gaap Gross Profit
GrossProfit
3000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7520 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8832 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25043 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
7520 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
8832 usd
us-gaap Operating Expenses
OperatingExpenses
31025 usd
us-gaap Operating Expenses
OperatingExpenses
25043 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1520 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7632 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22625 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22043 usd
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
701 usd
us-gaap Interest Income Other
InterestIncomeOther
1574 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
701 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1574 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1520 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6931 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22625 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20469 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1520 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6931 usd
us-gaap Net Income Loss
NetIncomeLoss
-22625 usd
us-gaap Net Income Loss
NetIncomeLoss
-20469 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29995000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-49477 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21105 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-70582 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1520 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-72102 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-6041 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-13538 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-19579 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-6931 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-26510 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
-2400 usd
us-gaap Net Income Loss
NetIncomeLoss
-22625 usd
us-gaap Net Income Loss
NetIncomeLoss
-20469 usd
us-gaap Depreciation
Depreciation
157 usd
us-gaap Depreciation
Depreciation
32 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1574 usd
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
1200 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24868 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20811 usd
ACHN Proceeds From Collection Of Notes Receivables
ProceedsFromCollectionOfNotesReceivables
52437 usd
ACHN Payments To Property Plant And Equipment
PaymentsToPropertyPlantAndEquipment
950 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
11900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11900 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51487 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12968 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30676 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14269 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17496 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1301 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
48172 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2014-12-29
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_zjg2vyBOYRXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86A_zQMbLInol3fi">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the Securities and Exchange Commission (the “SEC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P10Y
CY2019Q3 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
10000000 shares
us-gaap Development Costs
DevelopmentCosts
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-22625 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-262327 usd
CY2022Q3 ACHN Working Capital
WorkingCapital
-72799 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
70900 usd
CY2022Q1 us-gaap Due To Officers Or Stockholders Noncurrent
DueToOfficersOrStockholdersNoncurrent
59000 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3200 usd
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5600 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22625 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-43436 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
31323 usd
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
(“NOLs”) can be carried forever based on the 2017 Tax Cuts and Jobs Act
CY2022Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
37637 usd

Files In Submission

Name View Source Status
achn-20220930_cal.xml Edgar Link unprocessable
0001493152-22-031621-index-headers.html Edgar Link pending
0001493152-22-031621-index.html Edgar Link pending
0001493152-22-031621.txt Edgar Link pending
0001493152-22-031621-xbrl.zip Edgar Link pending
achn-20220930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
achn-20220930_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
achn-20220930_lab.xml Edgar Link unprocessable
achn-20220930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending